ERBB2 and neoplasm: HER2‐negative cases comprised 76.4%, while positive cases were 23.6%, and there was no correlation between TTK‐positive tumours and HER2‐negative subtypes (P = 0.666, Spearman's correlation coefficient = 0.867).